1 |
1-deoxynojirimycin |
Duvoglustat |
[1] D09605 D09605 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
2 |
1-deoxynojirimycin hydrochloride |
Duvoglustat |
[1] D09605 D09605 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
3 |
A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (neogaa) |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
4 |
Aav2/8lsphgaa |
- |
- |
- |
- |
256 [1] 256 💬 |
5 |
Acetaminophen |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 [14] 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
6 |
Albuterol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
012 [8] 12, 13, 86, 89, 113, 231, 256, 299 💬 |
7 |
Aldurazyme (laronidase) |
Laronidase |
[1] D04670 D04670 💬 |
IDUA [1] IDUA 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [2] 19, 256 💬 |
8 |
Alglucosidase alfa |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
9 |
Alglucosidase alfa (genetical recombination) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
10 |
Alglucosidase alfa (gz419829) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
11 |
Alglucosidase alfa (myozyme) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
12 |
Alglucosidase alfa (recombinant human acid alpha-glucosidase [rhgaa]) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
13 |
Alglucosidase alfa gz419829 |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
14 |
Alglucosidase alpha |
- |
- |
- |
- |
256 [1] 256 💬 |
15 |
Alpha-glucosidase |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
16 |
At2220 |
AT2220 |
- |
- |
- |
256 [1] 256 💬 |
17 |
At2221 |
- |
- |
- |
- |
256 [1] 256 💬 |
18 |
At2221 65 mg formulated capsules |
- |
- |
- |
- |
256 [1] 256 💬 |
19 |
At845 |
- |
- |
- |
- |
256 [1] 256 💬 |
20 |
Atb200 |
- |
- |
- |
- |
256 [1] 256 💬 |
21 |
Avalglucosidase alfa |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
22 |
Avalglucosidase alfa (neogaa) |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
23 |
Avalglucosidase alfa gz402666 |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
24 |
Avalglucosidase alfa(gz402666) |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
25 |
Beta-hydroxybuturate esters |
- |
- |
- |
- |
256 [1] 256 💬 |
26 |
Bmn 701 |
- |
- |
- |
- |
256 [1] 256 💬 |
27 |
Bortezomib |
Bortezomib |
[1] D03150 D03150 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
28 |
Cipaglucosidase alfa |
- |
- |
- |
- |
256 [1] 256 💬 |
29 |
Clenbuterol |
Clenbuterol |
[1] D07713 D07713 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
001 [4] 1 , 2 , 6 , 256 💬 |
30 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
31 |
Cyclophosphamide monohydrate |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
013 [4] 13, 60, 96, 256 💬 |
32 |
Deoxynojirimycin |
Duvoglustat |
[1] D09605 D09605 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
33 |
Deprakine |
- |
- |
- |
- |
256 [1] 256 💬 |
34 |
Diphenhydramine |
Diphenhydramine |
[6] D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 [8] 11, 49, 51, 70, 86, 96, 222, 256 💬 |
35 |
Duvoglustat |
Duvoglustat |
[1] D09605 D09605 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
36 |
Duvoglustat hcl |
Duvoglustat |
[1] D09605 D09605 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
37 |
Duvoglustat hydrochloride |
Duvoglustat |
[1] D09605 D09605 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
38 |
Enzyme replacement agent |
- |
- |
- |
- |
256 [1] 256 💬 |
39 |
Epilim |
- |
- |
- |
- |
256 [1] 256 💬 |
40 |
Epilim chrono 200 controlled released tablets |
- |
- |
- |
- |
256 [1] 256 💬 |
41 |
Epilim chrono 300 controlled released tablets |
- |
- |
- |
- |
256 [1] 256 💬 |
42 |
Epilim chrono 500 controlled released tablets |
- |
- |
- |
- |
256 [1] 256 💬 |
43 |
Filgrastim |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [27] 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
44 |
Genetic: recombinant adeno-associated virus acid alpha-glucosidase |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
45 |
Gilt-rhgaa |
- |
- |
- |
- |
256 [1] 256 💬 |
46 |
Glucosidase alfa |
- |
- |
- |
- |
256 [1] 256 💬 |
47 |
Glycosade |
- |
- |
- |
- |
065 [3] 65, 256, 257 💬 |
48 |
Gz402666 |
- |
- |
- |
- |
256 [1] 256 💬 |
49 |
Intravenous immune globulin |
- |
- |
- |
- |
256 [1] 256 💬 |
50 |
Ketocal 4:1 liquid nutricia (intervention) |
- |
- |
- |
- |
256 [1] 256 💬 |
51 |
Laronidase |
Laronidase |
[1] D04670 D04670 💬 |
IDUA [1] IDUA 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [2] 19, 256 💬 |
52 |
Lidocaine |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [10] 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
53 |
Lmx 4 topical cream |
- |
- |
- |
- |
256 [1] 256 💬 |
54 |
Low carbohydrate ketogenic diet |
- |
- |
- |
- |
256 [1] 256 💬 |
55 |
Lumizyme |
- |
- |
- |
- |
256 [1] 256 💬 |
56 |
Lumizyme® |
- |
- |
- |
- |
256 [1] 256 💬 |
57 |
Mannose |
Mannose |
- |
- |
- |
013 [2] 13, 256 💬 |
58 |
Methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 [35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
59 |
Methotrexate sodium |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [2] 46, 256 💬 |
60 |
Miglustat |
Miglustat |
[1] D05032 D05032 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
019 [3] 19, 256, 299 💬 |
61 |
Miglustat (at2221) |
Miglustat |
[1] D05032 D05032 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
256 [1] 256 💬 |
62 |
Myozyme |
- |
- |
- |
- |
256 [1] 256 💬 |
63 |
Myozyme 50 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
256 [1] 256 💬 |
64 |
Myozyme® |
- |
- |
- |
- |
256 [1] 256 💬 |
65 |
Myozyme® (alglucosidase alfa) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
66 |
N.a. |
- |
- |
- |
- |
003 [10] 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
67 |
Neo-gaa |
- |
- |
- |
- |
256 [1] 256 💬 |
68 |
Neogaa |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
69 |
Neogaa or avalglucosidase alfa |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
70 |
Other: no treatment |
- |
- |
- |
- |
053 [2] 53, 256 💬 |
71 |
Other: rmst |
- |
- |
- |
- |
256 [1] 256 💬 |
72 |
Other: saline |
- |
- |
- |
- |
002 [8] 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
73 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
74 |
Plecebo |
- |
- |
- |
- |
256 [1] 256 💬 |
75 |
Pyridostigmine |
Pyridostigmine |
[1] D00487 D00487 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
003 [4] 3 , 6 , 11, 256 💬 |
76 |
Pyridostigmine bromide |
Pyridostigmine |
[1] D00487 D00487 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
003 [3] 3 , 6 , 256 💬 |
77 |
Raav1-cmv-gaa (study agent) administration |
- |
- |
- |
- |
256 [1] 256 💬 |
78 |
Rapamycin |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 [18] 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
79 |
Recombinant human ?-glucosidase conjugated with synthetic bismannose-6-phosphate-man6 glycan |
Phosphate ion |
- |
- |
- |
256 [1] 256 💬 |
80 |
Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (neogaa) |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
81 |
Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan avalglucosidase alfa (neogaa) |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
82 |
Recombinant human acid alfa-glucosidase |
- |
- |
- |
- |
256 [1] 256 💬 |
83 |
Recombinant human acid alfa-glucosidase (atb200) |
- |
- |
- |
- |
256 [1] 256 💬 |
84 |
Recombinant human acid alfa-glucosidase (rhgaa) |
- |
- |
- |
- |
256 [1] 256 💬 |
85 |
Recombinant human acid alpha-glucosidase (rhgaa) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
86 |
Ren001 |
ReN001 |
- |
- |
- |
256 [1] 256 💬 |
87 |
Reveglucosidase alfa |
- |
- |
- |
- |
256 [1] 256 💬 |
88 |
Reveglucosidase alpha |
- |
- |
- |
- |
256 [1] 256 💬 |
89 |
Rhgaa |
- |
- |
- |
- |
256 [1] 256 💬 |
90 |
Rhgaa, acid alpha glucosidase |
- |
- |
- |
- |
256 [1] 256 💬 |
91 |
Rituxan |
- |
- |
- |
- |
046 [4] 46, 60, 256, 288 💬 |
92 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
93 |
Salbutamol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 [9] 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
94 |
Sodium valproate |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 [4] 2 , 90, 102, 256 💬 |
95 |
Spk-3006 |
- |
- |
- |
- |
256 [1] 256 💬 |
96 |
Ss-hydroxybuturate esters |
- |
- |
- |
- |
256 [1] 256 💬 |
97 |
Triheptanoin |
Triheptanoin |
[1] D11465 D11465 💬 |
- |
- |
002 [9] 2 , 8 , 149, 156, 248, 256, 257, 317, 324 💬 |
98 |
Ux007 |
- |
- |
- |
- |
008 [4] 8 , 248, 256, 257 💬 |
99 |
Val-1221 |
- |
- |
- |
- |
256 [1] 256 💬 |
100 |
Valproate |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 [6] 2 , 3 , 90, 102, 233, 256 💬 |
101 |
Valproic acid |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [10] 3 , 5 , 26, 34, 65, 89, 90, 222, 256, 331 💬 |
102 |
Zavesca |
- |
- |
- |
- |
019 [3] 19, 256, 299 💬 |
103 |
Zavesca® prescription |
- |
- |
- |
- |
256 [1] 256 💬 |